Chugai Pharmaceutical (CHGCY) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free CHGCY Stock Alerts $15.22 +0.32 (+2.15%) (As of 05/31/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30, 2024 | americanbankingnews.comShort Interest in Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Rises By 3,125.0%May 11, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest UpdateChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 2,800 shares, a decrease of 94.7% from the April 15th total of 53,000 shares. Based on an average trading volume of 286,100 shares, the days-to-cover ratio is presently 0.0 days.April 27, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest Down 52.3% in AprilChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 53,000 shares, a drop of 52.3% from the March 31st total of 111,100 shares. Based on an average trading volume of 906,800 shares, the short-interest ratio is presently 0.1 days.April 26, 2024 | seekingalpha.comChugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Call TranscriptApril 23, 2024 | markets.businessinsider.comChugai Pharmaceutical is about to announce its earnings — here's what Wall Street expectsApril 10, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Sees Large Increase in Short InterestChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 111,100 shares, an increase of 439.3% from the March 15th total of 20,600 shares. Based on an average daily volume of 216,900 shares, the days-to-cover ratio is presently 0.5 days.March 30, 2024 | marketbeat.comShort Interest in Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Drops By 17.6%Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 20,600 shares, a drop of 17.6% from the February 29th total of 25,000 shares. Based on an average daily trading volume, of 135,600 shares, the days-to-cover ratio is currently 0.2 days.March 12, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest Up 635.3% in FebruaryChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 29th, there was short interest totalling 25,000 shares, a growth of 635.3% from the February 14th total of 3,400 shares. Based on an average daily trading volume, of 240,700 shares, the days-to-cover ratio is presently 0.1 days.February 25, 2024 | msn.comChugai Pharmaceutical Co., - Depositary Receipt () (CHGCY) Price Target Increased by 5.85% to 19.64February 21, 2024 | au.finance.yahoo.comChugai Pharmaceutical Co Ltd (CUP.HA)February 18, 2024 | seekingalpha.comWeek In Review: LianBio To Close Operations; Will Pay $528M To ShareholdersFebruary 17, 2024 | finance.yahoo.comChugai Pharmaceutical Co., Ltd. (CHGCY)February 16, 2024 | wsj.comChugai Pharmaceutical Co. Ltd. ADRFebruary 13, 2024 | au.finance.yahoo.comChugai Pharmaceutical Co Ltd (CUP.MU)February 6, 2024 | investing.comChugai Pharmaceutical Co., Ltd. (4519)January 25, 2024 | finance.yahoo.comU.S. Stocks Rise as Economic Growth ContinuesJanuary 25, 2024 | finance.yahoo.comU.S. Stocks Rise After Strong GDP DataJanuary 25, 2024 | finance.yahoo.comFutures Steady With More Earnings in FocusJanuary 24, 2024 | finance.yahoo.comNikkei Down 0.3%, Dragged by Tech, Pharmaceutical StocksJanuary 11, 2024 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Sees Large Decrease in Short InterestChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 2,500 shares, a decline of 89.9% from the December 15th total of 24,800 shares. Based on an average daily volume of 88,300 shares, the days-to-cover ratio is presently 0.0 days.January 4, 2024 | morningstar.comChugai Pharmaceutical Co Ltd ADR CHGCYDecember 29, 2023 | marketbeat.comChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Sees Large Growth in Short InterestChugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY - Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 24,800 shares, an increase of 140.8% from the November 30th total of 10,300 shares. Based on an average trading volume of 100,400 shares, the short-interest ratio is presently 0.2 days.December 17, 2023 | seekingalpha.comWeek In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B DealDecember 16, 2023 | msn.comChugai Pharmaceutical Co Ltd - ADR (CHGCY) Price Target Increased by 14.02% to 19.28December 12, 2023 | finance.yahoo.comChugai Pharmaceutical Co., Ltd. (CUP0.MU)November 29, 2023 | morningstar.comChugai Pharmaceutical Co Ltd CUPNovember 18, 2023 | morningstar.comChugai Pharmaceutical Co LtdOctober 23, 2023 | markets.businessinsider.comChugai Pharmaceutical earnings: here's what to expectOctober 12, 2023 | finance.yahoo.comChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Is a Great Choice for 'Trend' Investors, Here's WhyOctober 5, 2023 | finance.yahoo.comChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Upgraded to Buy: Here's What You Should KnowSeptember 1, 2023 | investing.comTOPIX Pharmaceutical (IPHAM.T)August 19, 2023 | wsj.comChugai Pharmaceutical Co. Ltd.August 3, 2023 | msn.comChugai Pharmaceutical (CHGCF) Price Target Decreased by 6.55% to 30.71April 26, 2023 | markets.businessinsider.comHere's what to expect from Chugai Pharmaceutical's earnings reportApril 18, 2023 | seekingalpha.comCHGCY Chugai Pharmaceutical Co., Ltd.March 2, 2023 | msn.comChugai, Biofourmis expand team up on digital solutions to measure endometriosis painMarch 2, 2023 | finance.yahoo.comChugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related PainDecember 30, 2022 | seekingalpha.comRoche: Worthy Of Big Pharma Label, Maybe Not A 'Value Pick' YetDecember 14, 2022 | finance.yahoo.comVisiox Pharma Announces FDA Acceptance of New Drug Application for GlaucomaDecember 12, 2022 | benzinga.comShort Volatility Alert: Chugai Pharm CoApril 27, 2022 | seekingalpha.comChugai Pharmaceutical reports Q1 resultsApril 25, 2022 | seekingalpha.comChugai Pharmaceutical Co., Ltd. 2022 Q1 - Results - Earnings Call PresentationMarch 17, 2022 | msn.comThe Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive DataMarch 17, 2022 | nasdaq.comHas Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Outpaced Other Medical Stocks This Year?October 14, 2021 | finance.yahoo.comNew Four-year Data Show Sustained Relapse Reduction by Chugai’s Enspryng in People With Neuromyelitis Optica Spectrum Disorder (NMOSD)July 26, 2021 | seekingalpha.comChugai Pharmaceutical Co., Ltd. 2021 Q2 - Results - Earnings Call Presentation Get Chugai Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for CHGCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… CHGCY Media Mentions By Week CHGCY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CHGCY News Sentiment▼0.470.77▲Average Medical News Sentiment CHGCY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CHGCY Articles This Week▼20▲CHGCY Articles Average Week Get Chugai Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for CHGCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: McKesson News Cencora News Cardinal Health News Herbalife News Nu Skin Enterprises News PetIQ News HWH International News BIMI News Cosmos Health News TRxADE HEALTH News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CHGCY) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldAlert: Your Bank is Dying – Act Now or Lose Everything!Priority GoldNext President (Not Trump. Not Biden.)The Freeport SocietyWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHistoric Crash Could Wipe Away Your 401k (Govt Debt Explosion)Birch GoldPrepare for a Recession Unlike Any OtherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chugai Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.